The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20050135: CharterMac; Capri Realty Capital, LLC
20050133: Centene Corporation; Swope Community Enterprises
20050130: Rush Enterprises, Inc.; Jesse and Milo Kirk
20050126: Warburg Pincus Private Equity VIII, L.P.; Avicis, Inc.
20050113: Southern Wine & Spirits of America, Inc.; David Taub
20050122: Cypress Merchant Banking Partners II L.P.; Stone Canyon Entertainment Corp.
Appliance Labeling Rule - Agency Information Collection Activities; Proposed Collection; Comment Request; Extension
First American Payment Processing, Inc.; et al.
Related Identity Theft Definitions of Active Duty Alerts, and Appropriate Proof of Identity Under the Fair Credit Reporting Act - 16 CFR Parts 603, 613, and 614
20050117: Estate of Ernest L. Samuel; Mr. Charles E. Pompea
20050094: Wellspring Capital Partners III, LLP; The Stanley Works
20050081: William Sauder; Riverside Forest Products Limited
20050051: Cooper Cameron Corporation; Precision Castparts Corp.
Sanofi-Synthelabo and Aventis, In the Matter of
The consent order settled antitrust concerns that Sanofi's proposed $64 billion acquisition of Aventis would create significant overlaps in several markets for pharmaceutical products while creating the world's third largest pharmaceutical company. Under terms of the consent order, Sanofi must: 1) divest its Arixtra factor Xa inhibitor to GlaxoSmithKline, plc; 2) divest its key clinical studies for the Campto® cytotoxic colorectal cancer treatment to Pfizer, Inc. and 3) divest Aventis' contractual rights to the Estorra insomnia drug either to Sepracor, Inc. or to another Commission-approved buyer.